학술논문

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, September 2022, 173:210-218)
Subject
Language
English
ISSN
18790852
09598049